Glutamate (EAAT) Transporters

Glutamate transporter inhibitors and modulators act on the excitatory amino acid transporters (EAATs). Five subtypes, EAAT1 to EAAT5, use ion gradients to move glutamate from the synaptic cleft into astrocytes and neurons. Glutamate transporter 1 (GLT-1), the rodent form of EAAT2, accounts for most glutamate uptake in the forebrain. Mice lacking GLT-1 developed lethal spontaneous seizures and greater brain injury, which links this transporter to protection from excitotoxicity. DL-TBOA, described in 1998, blocks several EAAT subtypes without being transported. UCPH 101 selectively inhibits EAAT1, and WAY-213613 inhibits uptake through GLT-1/EAAT2. LDN-212320 raises GLT-1 expression, while GPNA hydrochloride inhibits the related alanine-serine-cysteine transporter 2 (ASCT2).

25 Items

  • ONO 2506
    Cat. No.
    A12404

    ONO 2506

    Synonyms: Arundic acid

    ONO 2506 inhibits S100B synthesis in activated cultured astrocytes.

    5 mg
    $30.00
    10 mg
    $55.00
    All 6 sizes
  • UCPH 101
    Cat. No.
    A13099

    UCPH 101

    UCPH 101 is a selective non-substrate inhibitor of EAAT1 (IC50 values are 660, >300000 and >300000 nM for EAAT1, EAAT2 and EAAT3 respectively).

    1 mg
    $40.00
    2 mg
    $75.00
    All 8 sizes
  • Evans Blue
    Cat. No.
    A16544

    Evans Blue

    Synonyms: Direct Blue 53; T-1824; C.I. 23860

    Evans Blue is a potent inhibitor of L-glutamate uptake through the membrane-bound excitatory amino acid transporter (EAAT). This compound effectively inhibits L-glutamate and kainate receptor-mediated currents, making it valuable for research into neurophysiological processes. Additionally, due to its strong affinity for serum albumin, Evans Blue serves as a high molecular weight protein tracer and is widely used to investigate blood-brain barrier (BBB) permeability.

    100 mg
    $20.00
    500 mg
    $25.00
    All 4 sizes
  • GT 949
    Cat. No.
    A18624

    GT 949

    GT 949 is a selective excitatory amino acid transporter-2 (EAAT2) positive allosteric modulator with an EC50 of 0.26 nM.

    5 mg
    $30.00
    10 mg
    $55.00
    All 7 sizes
  • WAY-213613
    Cat. No.
    A19992

    WAY-213613

    WAY-213613 is a potent, selective nonsubstrate reuptake inhibitor of GLT-1/EAAT2 with IC50 of 85 nM EAAT2.

    1 mg
    $180.00
    5 mg
    $180.00
    All 5 sizes
  • MPDC
    Cat. No.
    A20806

    MPDC

    MPDC is a potent and competitive inhibitor of the Na+-dependent high-affinity glutamate transporter in forebrain synaptosomes.

    5 mg
    $180.00
    10 mg
    $320.00
    All 5 sizes
  • GPNA hydrochloride
    Cat. No.
    A22452

    GPNA hydrochloride

    GPNA hydrochloride is a well known substrate of the enzyme γ-glutamyltransferase (GGT). GPNA hydrochloride is a specific glutamine (Gln) transporter ASCT2 inhibitor.

    5 mg
    $20.00
    10 mg
    $25.00
    All 6 sizes
  • DL-TBOA
    Cat. No.
    A66564

    DL-TBOA

    DL-TBOA is a potent non-transportable inhibitor of excitatory amino acid transporters (EAATs), specifically targeting EAAT1, EAAT2, and EAAT3 with IC50 values of 70 μM, 6 μM, and 6 μM, respectively. This compound effectively inhibits the uptake of [14C]glutamate in COS-1 cells expressing human EAAT1 and EAAT2, demonstrating Ki values of 42 μM and 5.7 μM, respectively. Additionally, DL-TBOA competitively blocks EAAT4 and EAAT5 with Ki values of 4.4 μM and 3.2 μM, respectively. This reagent is valuable for studying excitatory neurotransmission and related pathologies in research applications.

    5 mg
    $155.00
    10 mg
    $235.00
    All 2 sizes
  • LDN-212320
    Cat. No.
    A66565

    LDN-212320

    Synonyms: LDN-0212320; OSU-0212320

    LDN-212320 is a potent activator of the glutamate transporter GLT-1 (EAAT2), primarily functioning at the translational level. This compound is known to mitigate nociceptive pain by enhancing astroglial GLT-1 expression in both the hippocampus and anterior cingulate cortex. LDN-212320 is valuable in research focused on pain modulation and neuroprotection, offering insights into the role of glutamate transporters in neurological conditions.

    2 mg
    $25.00
    5 mg
    $45.00
    All 7 sizes
  • TFB-TBOA
    Cat. No.
    A66566

    TFB-TBOA

    Synonyms: CF3-Bza-TBOA

    TFB-TBOA is a potent blocker of glutamate transporters, specifically targeting EAAT1, EAAT2, and EAAT3. It demonstrates competitive inhibition with IC50 values of 22 nM for EAAT1, 17 nM for EAAT2, and 300 nM for EAAT3, effectively suppressing their transport activity. This compound is valuable for research applications investigating glutamate signaling and transporter function in neurobiology and related fields.

    1 mg
    $175.00
    5 mg
    $450.00
    All 3 sizes
  • WAY-213613 hydrochloride
    Cat. No.
    A66567

    WAY-213613 hydrochloride

    WAY-213613 hydrochloride is a potent and selective inhibitor of the human excitatory amino acid transporter 2 (EAAT2). With an IC50 value of 85 nM, it effectively modulates glutamate transport, making it a valuable tool for investigating glutamatergic signaling in the central nervous system. This compound is suitable for research applications exploring neurobiology and potential therapeutic interventions related to neurodegenerative diseases.

    1 mg
    $25.00
    5 mg
    $65.00
    All 7 sizes
  • NA-014
    Cat. No.
    A66569

    NA-014

    NA-014 is a selective positive allosteric modulator (PAM) of the excitatory amino acid transporter 2 (EAAT2), exhibiting an EC50 of 3 nM. This compound enhances the transport activity of EAAT2, which is crucial for regulating glutamate levels in the synaptic cleft. NA-014 is valuable for research into neurodegenerative diseases and synaptic dysfunction, providing insights into therapeutic strategies that target glutamate homeostasis.

    5 mg
    $180.00
    10 mg
    $295.00
    All 5 sizes
  • UCPH-102
    Cat. No.
    A66571

    UCPH-102

    UCPH-102 is a highly selective inhibitor of the excitatory amino acid transporter 1 (EAAT1), exhibiting an IC50 value of 0.43 µM. This compound demonstrates significant anti-proliferative effects on T-cell acute lymphoblastic leukemia (T-ALL) cells. Furthermore, UCPH-102's favorable blood-brain barrier permeability makes it a valuable tool for research in neurodegenerative diseases such as amyotrophic lateral sclerosis and Alzheimer’s disease, as well as conditions related to chronic pain and obsessive-compulsive disorder.

    5 mg
    $245.00
    10 mg
    $405.00
    All 5 sizes
  • L-threo-3-Hydroxyaspartic acid
    Cat. No.
    A66572

    L-threo-3-Hydroxyaspartic acid

    L-threo-3-Hydroxyaspartic acid functions as a selective inhibitor of excitatory amino acid transporters (EAATs), exhibiting inhibitory constants (Kis) of 11, 19, and 14 μM for EAAT1, EAAT2, and EAAT3, respectively, in HEK293 cell lines. This compound plays a crucial role in the study of neurotransmitter regulation and excitotoxicity, making it valuable for research related to neurological disorders and synaptic transmission. Its ability to modulate glutamate signaling contributes to understanding potential therapeutic pathways for conditions such as epilepsy and neurodegenerative diseases.

    1 mg
    $130.00
    5 mg
    $335.00
    All 3 sizes
  • Nε-(Carboxyethyl)lysine
    Cat. No.
    A66573

    Nε-(Carboxyethyl)lysine

    Nε-(Carboxyethyl)lysine is a known modulator of excitatory amino acid transporters (EAATs). As an advanced glycation end product (AGE), it facilitates protein cross-linking, leading to alterations in protein structure and function, ultimately resulting in protein denaturation. Nε-(Carboxyethyl)lysine interacts with RAGE receptors, influencing cell signaling pathways critical for inflammatory response, cell proliferation, and apoptosis. Additionally, it affects glutamate transporter activity, reducing glutamate uptake and S100B protein secretion, thereby impacting neurotransmission and demonstrating neurotoxic effects associated with diabetes.

    1 mg
    $80.00
    5 mg
    $200.00
    All 3 sizes
  • EAAT2 activator 1
    Cat. No.
    A66574

    EAAT2 activator 1

    EAAT2 Activator 1 is a potent activator of the excitatory amino acid transporter 2 (EAAT2), a critical protein responsible for the clearance of glutamate from synaptic clefts. This compound enhances EAAT2 protein levels in a dose-dependent manner, promoting efficient glutamate uptake. EAAT2 Activator 1 is relevant for research applications aimed at understanding glutamatergic signaling and neuroprotection in various neurological disorders.

    5 mg
    $25.00
    10 mg
    $50.00
    All 6 sizes
  • (R)-AS-1
    Cat. No.
    A66575

    (R)-AS-1

    (R)-AS-1 is a selective positive allosteric modulator of the excitatory amino acid transporter 2 (EAAT2), exhibiting an EC50 of 11 nM. This compound enhances spontaneous locomotor activity in murine models at doses of 60 and 90 mg/kg. Additionally, (R)-AS-1 demonstrates significant anticonvulsant effects in various seizure models, with ED50 values of 66.3 mg/kg for maximal electroshock, 36.3 mg/kg for pentylenetetrazole, and 41.6 mg/kg for electrical stimuli. This agent is valuable for research in neurological disorders.

    1 mg
    $60.00
    5 mg
    $155.00
    All 5 sizes
  • SLC1A1/EAAT3-IN-1
    Cat. No.
    A66576

    SLC1A1/EAAT3-IN-1

    SLC1A1/EAAT3-IN-1 is a selective inhibitor of the excitatory amino acid transporter 3 (EAAT3), exhibiting an IC50 of 7.2 μM for human EAAT3 while showing significantly reduced inhibition of EAAT1, 2, and 4 (IC50: ~250 μM). This compound is primarily utilized in research related to psychiatric disorders, including obsessive-compulsive disorder and schizophrenia, and can aid in the investigation of neurotransmitter dynamics and therapeutic strategies targeting EAAT3.

    5 mg
    $120.00
    10 mg
    $195.00
    All 5 sizes
  • MS-153
    Cat. No.
    A66577

    MS-153

    MS-153 is a selective activator of glutamate transporters, facilitating the uptake of glutamate into neurons and glial cells. This compound exhibits neuroprotective properties, making it a valuable tool in the study of neurodegenerative diseases and excitotoxicity. Its ability to modulate glutamate levels in the synaptic cleft has implications for research into neurological disorders and potential therapeutic approaches.

    5 mg
    $115.00
    10 mg
    $185.00
    All 3 sizes
  • (±)-HIP-B
    Cat. No.
    A66578

    (±)-HIP-B

    (±)-HIP-B is a non-competitive blocker of excitatory amino acid transporters (EAATs), demonstrating effective inhibition of glutamate uptake with an IC50 of 17-18 μM. This compound serves as a valuable lead in research focused on ischemia-induced neuronal degeneration. Its application extends to the investigation of various neurological disorders, contributing to a deeper understanding of excitotoxicity and neuronal survival mechanisms.

    Out of stock

    All 3 sizes
  • DL-TBOA ammonium
    Cat. No.
    A66579

    DL-TBOA ammonium

    DL-TBOA ammonium is a selective inhibitor of excitatory amino acid transporters (EAATs), demonstrating IC50 values of 70 μM, 6 μM, and 6 μM for EAAT1, EAAT2, and EAAT3, respectively. This compound effectively inhibits the uptake of [14C]glutamate in COS-1 cells expressing human EAAT1 and EAAT2, with Ki values of 42 μM and 5.7 μM. Additionally, DL-TBOA ammonium competitively inhibits EAAT4 and EAAT5, featuring Ki values of 4.4 μM and 3.2 μM, respectively. Its distinct mechanism renders it a valuable tool for studies on excitatory neurotransmission and the role of glutamate transporters in neurological research.

    5 mg
    $795.00
    All 1 sizes
  • (±)-threo-3-Methylglutamic acid
    Cat. No.
    A66580

    (±)-threo-3-Methylglutamic acid

    (±)-threo-3-Methylglutamic acid is a potent inhibitor of excitatory amino acid transporters EAAT2 and EAAT4. It functions as an ionotropic glutamate receptor agonist and is effective in inhibiting glutamate uptake in rod outer segments. This compound is valuable for research applications focusing on glutamatergic signaling and transport mechanisms in the nervous system.

    10 mg
    $195.00
    50 mg
    $810.00
    All 2 sizes
  • DA-023
    Cat. No.
    A66581

    DA-023

    DA-023 is a selective positive allosteric modulator of the excitatory amino acid transporter 2 (EAAT2) with an EC50 value of 1 nM. This compound enhances EAAT2 activity, which is crucial for glutamate regulation in the central nervous system. DA-023 is particularly relevant for research into neurological diseases, offering potential insights into therapeutic strategies for conditions associated with glutamate dysregulation.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • (±)-HIP-A
    Cat. No.
    A66582

    (±)-HIP-A

    (±)-HIP-A is a non-competitive blocker of excitatory amino acid transporters (EAATs) that inhibits glutamate uptake with an IC50 value of 17-18 μM. This compound serves as a lead candidate for research into ischemia-induced neuronal degeneration. (±)-HIP-A is particularly valuable for studying the pathophysiology of neurological diseases and the mechanisms underlying excitotoxicity.

    25 mg
    $1,530.00
    50 mg
    $1,950.00
    All 3 sizes
  • cis-ACBD
    Cat. No.
    A68507

    cis-ACBD

    Synonyms: cis-1-Aminocyclobutane-1,3-dicarboxylic acid

    Cis-ACBD is a potent and selective inhibitor of the high-affinity, Na+-dependent plasma membrane glutamate transporter. As a glutamate reuptake inhibitor, it effectively hinders the uptake of D-[3H]aspartate in a linear competitive manner. This compound is valuable for research applications focusing on neurotransmitter dynamics and associated neurological disorders.

    1 mg
    $35.00
    2 mg
    $50.00
    All 7 sizes

25 Items

Added to your cart

View Cart Checkout

    Loading...